Adc Therapeutics Sa shares fall 1.88% after-hours as Sonnet Biotherapeutics, Inc. announces $888 million funding.

lunes, 14 de julio de 2025, 6:25 pm ET1 min de lectura
ADCT--
Adc Therapeutics Sa dropped 1.88% in after-hours trading. Sonnet Biotherapeutics, Inc. announced an 888-million-dollar deal, which may have caused investors to reassess the competitive landscape and potential market share for Adc Therapeutics Sa, leading to the decline in its stock price.

Adc Therapeutics Sa shares fall 1.88% after-hours as Sonnet Biotherapeutics, Inc. announces $888 million funding.

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios